Earnings History Data for PDL BioPharma, Inc. (PDLI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
PDL BioPharma, Inc.
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-11-2020 | PM | 4:05 PM ET (Nov 9) |
PDLI | PDL BioPharma, Inc. | 247.34 | N/A | 0.06 | 0.08 | PDL BioPharma reports Q3 results [11/11/2020 5:38 AM] |
2.26 | 0.04 (1.80%) |
2.22 | 0.0 (0.00%) |
1.86 - 3.50 | 828,100 | 871,259 | 29,778 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:05 PM ET (Aug 6) |
PDLI | PDL BioPharma, Inc. | 379.44 | -0.20 | 0.10 | 0.09 | PDL BioPharma EPS misses by $0.21, misses on revenue [8/6/2020 4:13 PM] |
3.10 | -0.40 (-11.41%) |
3.02 | -0.48 (-13.84%) |
1.68 - 3.52 | 669,525 | 1,058,974 | 1,825 | |
|
|
||||||||||||||||||